Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
En este video de discusión, el Dr. Narjust Duma habla con los Dres. Idalid "Ivy" Franco (Programa de Radiación Oncológica de Harvard), Ana Velázquez Manana (UCSF Helen Diller Family Comprehensive Cancer Center) y Luis Raez (Jefe de Hematología / Oncología y Director Médico - Memorial Cancer Institute) sobre cómo COVID 19 ha afectado la detección del cáncer en el comunidad latina, y la disminución en el diagnóstico de cáncer que se ha convertido en un problema en los Estados Unidos e internacionalmente.
*****
In this video discussion, Dr. Narjust Duma speaks with Drs. Idalid "Ivy" Franco (Harvard Radiation Oncology Program), Ana Velazquez Manana (UCSF Helen Diller Family Comprehensive Cancer Center) and Luis Raez (Chief Hematology/Oncology and Medical Director - Memorial Cancer Institute) about how COVID 19 has effected cancer screening in the latino community, and the decrease in cancer diagnosis that has become a problem in the US and internationally.
Para unirse a la conversación, visite https://cancergrace.org/forum.
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Hi James Anthony, I'm so sorry you are going through this and so very young. It' s true that some people benefit for years with chemo and targeted therapies. With the...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.